Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med. 1996;335:1107 1114. doi: 10.1056/NEJM199610103351504. 73. Cohn JN, Ziesche S, Smith R, Anand I, Dunkman WB, Loeb H, Cintron G, Boden W, Baruch L, Rochin P, Loss L. Effect of the calcium antagonist felodipine as supplementary vasodilator ther- apy in patients with chronic heart failure treated with enalapril: V-HeFT III: Vasodilator-Heart Failure Trial (V-HeFT) Study Group. Circulation. 1997;96:856 863. 74. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Asso- ciation Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51:1403 1419. doi: 10.1161/HYPERTENSIONAHA.108.189141. 75. Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomen- ko A, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat Management of Comorbidities in Chronic Heart Failure CLINICAL STATEMENTS AND GUIDELINES P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, B hm M, Anker SD, Thompson SG, Poole-Wilson PA; SENIORS Investigators. Ran- domized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J. 2005;26:215 225. doi: 10.1093/ eurheartj/ehi115. 76. Pape D, Goineau S, Guillo P, Ram e MP, Bellissant E. Early anti- remodeling effect of labetalol in the congestive heart failure mod- el induced by aortic constriction in the guinea pig. J Cardiovasc Pharmacol. 2002;39:746 753. 77. Loeb HS, Johnson G, Henrick A, Smith R, Wilson J, Cremo R, Cohn JN. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic conges- tive heart failure: the V-HeFT VA Cooperative Studies Group. Circulation. 1993;87(suppl):VI78 VI87. 78. 